Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 12:01 save search
Prelude Therapeutics To Participate in Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
PRLD | $3.73 8.43% 32K
|
Health Technology
|
| O: -1.04%
H: 2.88%
C: -2.62%
conference therapeutics
Celldex Announces First Patient Dosed in Phase 1 Study of CDX-585 in Patients with Advanced Malignancies
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
CLDX | $37.08 -3.76% 220K
|
Health Technology
|
| O: 0.35%
H: 4.22%
C: 1.63%
cdx-585 study
Panbela Announces 1-for-30 Reverse Stock Split Effective June 1, 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
PBLA | $0.4895 66K
|
Professional, Scientific, and T...
|
| O: -26.47%
H: 15.16%
C: -9.96%
Enlivex Selected for an Elevator Pitch Presentation and two additional Poster Presentations at the 2023 Annual Meeting of the International Society for Cell & Gene Therapy
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
ENLV | $1.4 64K
|
Health Technology
|
| O: -1.14%
H: 1.15%
C: 0.77%
presentation international cell meeting therapy
Fate Therapeutics to Present at Upcoming June Investor Conferences
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
FATE | $4.85 -3.77% 1.3M
|
Health Technology
|
| O: 0.0%
H: 6.25%
C: 1.81%
therapeutics
Mineralys Therapeutics to Participate in the Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
MLYS M | $11.09 3.16% 55K
|
|
| O: 1.89%
H: 3.43%
C: -0.27%
conference therapeutics
Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
RANI | $6.82 12.73% 130K
|
|
| O: 1.2%
H: 0.0%
C: -3.32%
conference presentation therapeutics
Akero Therapeutics to Present at the Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
AKRO | $20.525 0.07% 340K
|
Health Technology
|
| O: -0.18%
H: 3.83%
C: 1.76%
conference therapeutics
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference - May 31, 2023
Published: 2023-05-31 (Crawled : 12:01) - biospace.com/
BCYC | $23.2 -5.27% 480K
|
Health Technology
|
| O: 0.21%
H: 2.68%
C: -0.5%
conference bicycle therapeutics
Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
AQST | $4.15 -7.78% 1.6M
|
Health Technology
|
| O: 0.97%
H: 12.5%
C: 11.06%
positive therapeutics results study
Intellia Therapeutics to Present Updated Interim Data from Ongoing Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Hybrid Congress 2023
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
NTLA | $20.99 -1.55% 560K
|
Health Technology
|
| O: -0.75%
H: 3.7%
C: -0.03%
ntla-2002 treatment ongoing therapeutics study
Fulcrum Therapeutics Announces CEO Transition
Published: 2021-03-04 (Crawled : 12:01) - globenewswire.com
FULC | $6.79 -3.82% 390K
|
Health Technology
|
| O: -2.13%
H: 0.43%
C: -12.46%
ceo leo therapeutics
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2021
Published: 2021-02-25 (Crawled : 12:01) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.0%
H: 3.03%
C: 0.0%
Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
Published: 2021-02-24 (Crawled : 12:01) - globenewswire.com
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: 1.94%
H: 4.25%
C: 0.76%
gene therapy therapy gene therapies preclinical pre-clinical designation
Silence Therapeutics plc Announces $45 Million Private Placement
Published: 2021-02-05 (Crawled : 12:01) - globenewswire.com
SLN | $22.88 3.91% 190K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.68%
therapeutics
Orchard Therapeutics Announces $150 Million Strategic Financing
Published: 2021-02-05 (Crawled : 12:01) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 8.52%
H: 15.11%
C: 9.48%
therapeutics
Iterum Therapeutics Announces Collaboration with EVERSANA to Support Oral Sulopenem Launch
Published: 2021-02-01 (Crawled : 12:01) - globenewswire.com
ITRM | $1.43 34K
|
Health Technology
|
| O: 8.51%
H: 4.58%
C: 1.31%
collaboration announces collaboration sulopenem
AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway
Published: 2021-01-29 (Crawled : 12:01) - globenewswire.com
ACIU | $2.355 -1.05% 18K
|
Health Technology
|
| O: 2.77%
H: 0.0%
C: -5.08%
program
Pluristem Announces Uplisting to the Nasdaq Global Market®
Published: 2021-01-27 (Crawled : 12:01) - globenewswire.com
PSTI | $1.0 -2.91% 8.0%
|
Health Technology
|
| O: -1.78%
H: 3.77%
C: -1.26%
nasdaq
European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
Published: 2021-01-27 (Crawled : 12:01) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -0.51%
H: 11.09%
C: 7.51%
disease treatment anemia oxbryta authorized application
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.